Skip to main content
Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.7265
+0.0265 (3.79%)
At close: Apr 2, 2025, 4:00 PM
0.6963
-0.0302 (-4.16%)
After-hours: Apr 2, 2025, 7:56 PM EDT

Salarius Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-5.58-12.54-31.61-12.77-7.35
Upgrade
Depreciation & Amortization
00.010.010.020.02
Upgrade
Asset Writedown & Restructuring Costs
--10.85--
Upgrade
Stock-Based Compensation
0.270.520.80.560.32
Upgrade
Other Operating Activities
-0.13-0.01-0.04-0.26
Upgrade
Change in Accounts Receivable
-1.48-2.25-3.86
Upgrade
Change in Accounts Payable
0.33-2.261.31-0.31-0
Upgrade
Change in Unearned Revenue
-----0.54
Upgrade
Change in Other Net Operating Assets
0.44-0.191.060.11.36
Upgrade
Operating Cash Flow
-4.53-12.85-17.6-10.2-10.31
Upgrade
Capital Expenditures
-----0
Upgrade
Sale (Purchase) of Intangibles
---1.5--
Upgrade
Investing Cash Flow
---1.5--0
Upgrade
Short-Term Debt Repaid
-0.47-0.28--0.48-0.97
Upgrade
Total Debt Repaid
-0.47-0.28--0.48-0.97
Upgrade
Net Debt Issued (Repaid)
-0.47-0.28--0.48-0.97
Upgrade
Issuance of Common Stock
1.536.921.9928.7718.67
Upgrade
Financing Cash Flow
1.066.641.9928.317.69
Upgrade
Net Cash Flow
-3.47-6.21-17.1118.17.38
Upgrade
Free Cash Flow
-4.53-12.85-17.6-10.2-10.31
Upgrade
Free Cash Flow Margin
----554.29%-197.08%
Upgrade
Free Cash Flow Per Share
-4.70-31.48-66.26-49.32-132.41
Upgrade
Cash Interest Paid
0.010.01-00.01
Upgrade
Levered Free Cash Flow
-2.96-8.99-14.37-3.89-8.77
Upgrade
Unlevered Free Cash Flow
-2.96-8.99-14.37-3.89-8.77
Upgrade
Change in Net Working Capital
-0.351.46-0.69-3.544.24
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q